Found 57 clinical trials
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Family Medicine
-
Currently Recruiting
Cutaneous Squamous Cell Carcinoma
People with cutaneous squamous cell carcinoma are asked to participate in a research study being conducted by Northwell Health, Inc.
- 24 views
- 23 Nov, 2020
- 1 location
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Family Medicine
-
Currently Recruiting
CEMIPLIMAB SURVIVORSHIP EPIDEMIOLOGY (CASE) STUDY
People with cutaneous squamous cell carcinoma are asked to participate in a research study being conducted by Montefiore Medical Center.
- 9 views
- 01 Aug, 2019
- 1 location
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
Family Medicine
-
Currently Recruiting
CEMIPLIMAB SURVIVORSHIP EPIDEMIOLOGY (CASE) STUDY
People with cutaneous squamous cell carcinoma are asked to participate in a research study being conducted by Monter Cancer Center.
- 23 views
- 02 Aug, 2019
- 1 location
-
Phase 3 trial
-
Accepting pediatric ages
-
Currently Recruiting
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Investigational Product in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Investigational Product in Patients With Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC)
- 206 views
- 08 Nov, 2020
- 1 location
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
Currently Recruiting
Do you suffer from Hemorrhoids?
Do you suffer from Hemorrhoids?
- 1312 views
- 08 Nov, 2020
- 1 location
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
Currently Recruiting
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
- 106 views
- 08 Dec, 2020
- 1 location
-
Multi-country trial
-
Phase 2 trial
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For all genders
-
Currently Recruiting
Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma
For Groups 1 to 4, the primary objective of this study is to estimate the clinical benefit of cemiplimab monotherapy for patients with: metastatic (nodal or distant) cutaneous squamous cell
- 0 views
- 25 Jan, 2021
- 101 locations
-
Multi-country trial
-
Phase 3 trial
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An interventional trial
-
For all genders
-
Family Medicine
-
Currently Recruiting
Pembrolizumab Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)
This is a randomized, double-blind, study that compares pembrolizumab with placebo given as adjuvant therapy in participants with high-risk locally advanced cutaneous squamous cell carcinoma (LA
- 69 views
- 18 Jan, 2021
- 132 locations
-
Unknown Phase
-
Accepting Seniors
-
Accepting adults
-
10s of participants
-
An interventional trial
-
For all genders
-
Currently Recruiting
Biological Outcomes of Pramlintide in Resectable Cutaneous Squamous Cell Carcinoma: A Pilot Study
This study will treat resectable cutaneous squamous cell carcinoma patients with pramlintide for two weeks prior to surgical resection of their tumor. Pre-treatment and surgical resection
- 0 views
- 25 Jan, 2021
- 1 location
-
Phase 1 trial
-
Accepting Seniors
-
Accepting adults
-
10s of participants
-
An interventional trial
-
For all genders
-
Currently Recruiting
Pre-Operative Cemiplimab Administered Intralesionally for Patients With Recurrent Cutaneous Squamous Cell Carcinoma
The primary objective is to characterize the safety and tolerability of cemiplimab injected intralesionally in patients with recurrent CSCC. The secondary objectives of this study are: To describe the objective response rate (ORR) in CSCC index lesions following intralesional injections of cemiplimab in patients with recurrent CSCC, according to modified …
- 1 views
- 25 Jan, 2021
- 9 locations